scholarly article | Q13442814 |
P50 | author | Carmen Ezpeleta | Q104748687 |
Itziar Casado | Q39700267 | ||
Iván Martínez-Baz | Q39700308 | ||
Marcela Guevara | Q39700348 | ||
P2093 | author name string | Jesús Castilla | |
Josu Delfrade | |||
Aitziber Aguinaga | |||
Ana Navascués | |||
Jorge Díaz-González | |||
Network For Influenza Surveillance In Hospitals Of Navarre | |||
Primary Health Care Sentinel Network Of Navarre | |||
P2860 | cites work | Serious morbidity and mortality associated with influenza epidemics | Q40246988 |
Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results | Q40357312 | ||
Influenza vaccine effectiveness against hospitalisation with influenza in adults in Australia in 2014. | Q40925285 | ||
Trivalent inactivated seasonal influenza vaccine effectiveness for the prevention of laboratory-confirmed influenza in a Scottish population 2000 to 2009. | Q41289347 | ||
2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals | Q41540629 | ||
Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. | Q42227573 | ||
Influenza vaccination and risk of hospitalization among adults with laboratory confirmed influenza illness | Q44460142 | ||
Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. | Q54272482 | ||
Influenza Vaccine Effectiveness in Preventing Outpatient, Inpatient, and Severe Cases of Laboratory-Confirmed Influenza | Q56791503 | ||
Influenza-associated hospitalizations in the United States | Q29619463 | ||
Estimating influenza disease burden from population-based surveillance data in the United States | Q30204564 | ||
Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus | Q30401497 | ||
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis | Q30408691 | ||
Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study | Q30428316 | ||
Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons | Q34393525 | ||
Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies | Q34451202 | ||
Evidence of bias in estimates of influenza vaccine effectiveness in seniors | Q34478438 | ||
Influenza vaccine effectiveness in preventing influenza A(H3N2)-related hospitalizations in adults targeted for vaccination by type of vaccine: a hospital-based test-negative study, 2011-2012 A(H3N2) predominant influenza season, Valencia, Spain | Q34505958 | ||
Time lines of infection and disease in human influenza: a review of volunteer challenge studies | Q34743132 | ||
Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review | Q34778408 | ||
Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses | Q35130915 | ||
Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type | Q35531934 | ||
Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population. | Q35874111 | ||
Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus. | Q35887612 | ||
Effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2013 | Q36232932 | ||
Influenza vaccine effectiveness by test-negative design - Comparison of inpatient and outpatient settings | Q36783905 | ||
Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza Higher Than Expected in Hospitalized Adults: 2014-2015. | Q38406947 | ||
Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | Q38803189 | ||
Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010-2011. | Q39530697 | ||
Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season | Q39700135 | ||
Influenza vaccine effectiveness in general practice and in hospital patients in Victoria, 2011-2013. | Q40048651 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P921 | main subject | influenza vaccine | Q383260 |
P577 | publication date | 2018-01-01 | |
P1433 | published in | Eurosurveillance | Q14565070 |
P1476 | title | Comparison of influenza vaccine effectiveness in preventing outpatient and inpatient influenza cases in older adults, northern Spain, 2010/11 to 2015/16. | |
P478 | volume | 23 |
Q91871266 | Cost-effectiveness of introducing national seasonal influenza vaccination for adults aged 60 years and above in mainland China: a modelling analysis |
Q92942088 | Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019 |
Q90692852 | The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology |
Search more.